Subscribe
The Aducanumab Aftermath: The Doctor

Tradeoffs

The Aducanumab Aftermath: The Doctor

A costly, controversial new Alzheimer’s drug is sending shockwaves through the U.S. health care system. How are doctors grappling with questions about its safety and efficacy? This is the first…
June 22, 2021

The Aducanumab Aftermath: The Doctor

A costly, controversial new Alzheimer’s drug is sending shockwaves through the U.S. health care system. How are doctors grappling with questions about its safety and efficacy? This is the first episode in a special conversation series featuring different people reckoning with the potentially sweeping consequences this drug could have on millions of patients’ lives and billions of dollars in health care spending.

Guest: Winston Chiong, MD, PhD, Associate Professor of Neurology, University of California, San Francisco

Explore the full series and additional resources: https://tradeoffs.org/aducanumab

Read a transcript of this episode: https://tradeoffs.org/2021/06/22/aducanumab-doctor-transcript/

Sign up for our weekly newsletter to see what research health policy experts are reading right now, plus recommendations from our staff: bit.ly/tradeoffsnewsletter

Support this type of journalism today, with a gift: https://tradeoffs.org/donate

Follow us on Twitter: https://twitter.com/tradeoffspod

 


See acast.com/privacy for privacy and opt-out information.

You may also like

Top Health Podcasts. Delivered to Your Inbox and Eardrums.

Proudly supported by:

cover
S1.Ep1: The promise of Personalised Health: Is this the Future of Healthcare? An introduction to the promise and potential of personalised health